Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADIVKT: Immunosuppression Adjustment for SARS-CoV-2 Vaccination in Kidney Transplant Recipients
NCT05060991Phase 4Active, not recruiting
- Sponsor
- University of California, Davis
- Start
- Sep 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil, azathioprine in coronavirus disease 2019 (COVID-19), sponsored by University of California, Davis. Started Sep 2021; status: active, not recruiting.
02
Drugs
mycophenolate mofetilazathioprine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05060991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05060991.